Moves to companies by a small group of HHMI investigators shows the growing appeal of commercial- sector biological research jobs. Howard Hughes Medical Institute investigators are acknowledged to be among the most creative and accomplished basic researchers working in academic laboratories today. Yet even these top scientists sometimes feel the urge for a different set of challenges. Some long for the chance to develop useful new drugs and therapeutics based on their ideas or to run a larger,
Moves to companies by a small group of HHMI investigators shows the growing appeal of commercial- sector biological research jobs. |
Perhaps the clearest evidence of this can be found in a small, but growing band of researchers who have voluntarily given up the unusually generous support and intellectual freedom HHMI offers to pursue such alternative careers in industrial laboratories. The fact that some have been willing to move into industrial research, however, ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
